HOV vs. WST
Compare and contrast key facts about Hovnanian Enterprises, Inc. (HOV) and West Pharmaceutical Services, Inc. (WST).
Performance
HOV vs. WST - Performance Comparison
Loading graphics...
HOV vs. WST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HOV Hovnanian Enterprises, Inc. | 13.71% | -27.11% | -14.01% | 269.82% | -66.94% | 287.37% | 57.45% | 22.06% | -79.59% | 22.71% |
WST West Pharmaceutical Services, Inc. | -8.82% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
Fundamentals
HOV:
$719.81M
WST:
$18.22B
HOV:
$8.60
WST:
$6.79
HOV:
12.90
WST:
36.93
HOV:
0.25
WST:
5.93
HOV:
1.03
WST:
5.74
HOV:
$2.94B
WST:
$3.07B
HOV:
$1.65B
WST:
$1.10B
HOV:
$637.73M
WST:
$723.60M
Returns By Period
In the year-to-date period, HOV achieves a 13.71% return, which is significantly higher than WST's -8.82% return. Over the past 10 years, HOV has underperformed WST with an annualized return of 11.31%, while WST has yielded a comparatively higher 13.95% annualized return.
HOV
- 1D
- 3.33%
- 1M
- -11.71%
- YTD
- 13.71%
- 6M
- -13.68%
- 1Y
- 5.92%
- 3Y*
- 17.80%
- 5Y*
- -1.02%
- 10Y*
- 11.31%
WST
- 1D
- 2.24%
- 1M
- -1.45%
- YTD
- -8.82%
- 6M
- -4.29%
- 1Y
- 12.35%
- 3Y*
- -9.99%
- 5Y*
- -2.27%
- 10Y*
- 13.95%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HOV vs. WST — Risk / Return Rank
HOV
WST
HOV vs. WST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hovnanian Enterprises, Inc. (HOV) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HOV | WST | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.09 | 0.30 | -0.21 |
Sortino ratioReturn per unit of downside risk | 0.61 | 0.83 | -0.22 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.10 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 0.16 | 0.53 | -0.37 |
Martin ratioReturn relative to average drawdown | 0.32 | 1.10 | -0.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| HOV | WST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.09 | 0.30 | -0.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.02 | -0.06 | +0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.15 | 0.41 | -0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | 0.37 | -0.39 |
Correlation
The correlation between HOV and WST is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
HOV vs. WST - Dividend Comparison
HOV has not paid dividends to shareholders, while WST's dividend yield for the trailing twelve months is around 0.34%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HOV Hovnanian Enterprises, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WST West Pharmaceutical Services, Inc. | 0.34% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
Drawdowns
HOV vs. WST - Drawdown Comparison
The maximum HOV drawdown since its inception was -99.70%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for HOV and WST.
Loading graphics...
Drawdown Indicators
| HOV | WST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.70% | -59.29% | -40.41% |
Max Drawdown (1Y)Largest decline over 1 year | -38.35% | -24.70% | -13.65% |
Max Drawdown (5Y)Largest decline over 5 years | -76.69% | -59.29% | -17.40% |
Max Drawdown (10Y)Largest decline over 10 years | -93.52% | -59.29% | -34.23% |
Current DrawdownCurrent decline from peak | -93.94% | -46.22% | -47.72% |
Average DrawdownAverage peak-to-trough decline | -70.12% | -16.79% | -53.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.54% | 12.05% | +7.49% |
Volatility
HOV vs. WST - Volatility Comparison
Hovnanian Enterprises, Inc. (HOV) has a higher volatility of 10.87% compared to West Pharmaceutical Services, Inc. (WST) at 9.11%. This indicates that HOV's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| HOV | WST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.87% | 9.11% | +1.76% |
Volatility (6M)Calculated over the trailing 6-month period | 43.65% | 24.91% | +18.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.72% | 41.43% | +25.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.70% | 40.04% | +25.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.36% | 34.28% | +41.08% |
Financials
HOV vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Hovnanian Enterprises, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HOV vs. WST - Profitability Comparison
HOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Hovnanian Enterprises, Inc. reported a gross profit of 612.94M and revenue of 631.95M. Therefore, the gross margin over that period was 97.0%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.
HOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Hovnanian Enterprises, Inc. reported an operating income of 562.66M and revenue of 631.95M, resulting in an operating margin of 89.0%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.
HOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Hovnanian Enterprises, Inc. reported a net income of 20.86M and revenue of 631.95M, resulting in a net margin of 3.3%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.